Literature DB >> 17552386

Preemptive sub-Tenon's anesthesia for pars plana vitrectomy under general anesthesia: is it effective?

John O Mason1, Peter L Goodwin, Richard M Feist, Rachel S Vail.   

Abstract

BACKGROUND AND OBJECTIVES: To determine whether irrigation of the sub-Tenon's space with anesthetic agents during pars plana vitrectomy (PPV) involving general anesthesia decreases postoperative pain, analgesic use, or nausea. PATIENTS AND METHODS: A prospective, controlled trial of 46 consecutive patients requesting general anesthesia for PPV who were randomized to receive or not receive a sub-Tenon's space injection prior to surgery. A mixture of 3 mL of 2% lidocaine with hyaluronidase and 3 mL of 0.5% bupivacaine was used to induce local blockade. Pain, postoperative nausea, and analgesia use were evaluated.
RESULTS: Local blockade did not significantly alter the proportion of reported pain at 30 minutes and 2, 4, and 24 hours after the operation. The local blockade had no effect on reducing postoperative nausea or the number of patients requiring pain medication.
CONCLUSIONS: Local blockade prior to surgery in patients undergoing PPV under general anesthesia does not significantly decrease postoperative pain, analgesic use, or nausea.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17552386     DOI: 10.3928/15428877-20070501-04

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  2 in total

1.  Postoperative Analgesic Efficacy of Sub-Tenon's Block with Levobupivacaine in Retinal Surgery under General Anesthesia.

Authors:  Ola T Abdeldayem; Ghada F Amer; Mohamed G Abdulla
Journal:  Anesth Essays Res       Date:  2019 Jul-Sep

2.  Preventive Analgesia, Hemodynamic Stability, and Pain in Vitreoretinal Surgery.

Authors:  Michał Jan Stasiowski; Aleksandra Pluta; Anita Lyssek-Boroń; Magdalena Kawka; Lech Krawczyk; Ewa Niewiadomska; Dariusz Dobrowolski; Robert Rejdak; Seweryn Król; Jakub Żak; Izabela Szumera; Anna Missir; Przemysław Jałowiecki; Beniamin Oskar Grabarek
Journal:  Medicina (Kaunas)       Date:  2021-03-12       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.